Dry Powder Inhalers (DPIs) are employed to supply a safe dose of Active Pharmaceutical Ingredient (API) to the deep lung. Image Credit: Freeman Technology An excipient transports the delicate ...
A dry powder inhaler formulation provides excellent protection against pneumonia-causing bacteria, scientists report. Community-acquired pneumonia, a type of lung inflammation contracted outside of a ...
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "INBRIJA Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering. This report provides comprehensive ...
The divided solid materials have a significant share in the products produced or employed in the pharmaceutical industries (such as active pharmaceutical ingredient (API), excipients, additives, and ...
Join this webcast to learn formulation strategies to eliminate cold chain requirements for proteins using dry powders manufactured by spray drying. Inhaled delivery of biotherapeutic active ...
LONDON, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, announces that it will present ...
According to Future Market Insights, the global market for dry powder inhaler is slated to exhibit a CAGR of nearly 4.6% during the forecast period (2021-2031), in terms of volume. Over 4000,000 Mn ...
According to Future Market Insights, the global market for Dry Powder Inhaler is slated to exhibit a CAGR of nearly 4% during the forecast period (2017-2026), in terms of volume. Over 4000,000 Mn ...
The Food and Drug Administration (FDA) has approved Teva's ProAir RespiClick (albuterol sulfate inhalation powder), the first breath-actuated dry-powder inhaler approved for acute asthma symptoms.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback